Tandem Diabetes Care (TNDM) Accumulated Depreciation & Amortization (2016 - 2025)
Tandem Diabetes Care (TNDM) has disclosed Accumulated Depreciation & Amortization for 12 consecutive years, with $16.6 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 5.68% year-over-year to $16.6 million, compared with a TTM value of $16.6 million through Dec 2024, up 5.68%, and an annual FY2024 reading of $16.6 million, up 5.68% over the prior year.
- Accumulated Depreciation & Amortization was $16.6 million for Q4 2024 at Tandem Diabetes Care, up from $15.7 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $16.6 million in Q4 2024 and bottomed at $10.5 million in Q4 2020.
- Average Accumulated Depreciation & Amortization over 5 years is $14.2 million, with a median of $14.3 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization soared 72.12% in 2020, then increased 3.5% in 2022.
- Year by year, Accumulated Depreciation & Amortization stood at $10.5 million in 2020, then soared by 32.48% to $13.8 million in 2021, then grew by 3.5% to $14.3 million in 2022, then rose by 9.67% to $15.7 million in 2023, then increased by 5.68% to $16.6 million in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for TNDM at $16.6 million in Q4 2024, $15.7 million in Q4 2023, and $14.3 million in Q4 2022.